Presents data on factors that affect the sensitivity of ADCC assays and discusses how to optimise methodology Glasgow, UK – November 10, 2015: Sartorius Stedim Biotech (SSB) BioOutsource today announced a new paper entitled, ‘As easy as ADCC’ has been published in the respected journal, European Biopharmaceutical Review. The article outlines the factors affecting the More
Scientific poster from the BPI conference looking at orthogonal approaches for humira biosimilars.
Read our biosimilar testing services brochure.
Scientific poster from the recent BEBPA conference looking at an interesting statistical approach for reporting potency of biosimilars.
Extensive regulatory requirements for analytical characterisation are now needed to prove comparability between innovator and biosimilar drugs. As a result, many developers are turning to ADCC assays which can help to unpick the issues of similarity, as well as guide the design process to create molecules to target specific activity. Download our article to find out more about the importance More
Cutting edge insight into the challenges of Biosimilar comparability studies View webinar here.
Why One Size Doesn’t Always Fit All – Scientific poster on SPR binding methodologies using Biacore.
Associate Director of Technical Services, Catriona Thomson, writes about the development of a biosimilar.
Doubles the Company’s Capacity for Biologics Contract Testing and Biosimilar Characterisation in Response to Surging Demand, and Creates 50 New Jobs Glasgow, Scotland, July 27, 2015 – BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, today announced the opening More